| 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of BHLHE41 mRNA | CTD | PMID:21983209 |
| 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of BHLHE41 mRNA | CTD | PMID:15576828 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of BHLHE41 mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | multiple interactions | ISO | RGD:731061 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of BHLHE41 mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BHLHE41 mRNA | CTD | PMID:22808131 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:731061 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of BHLHE41 mRNA | CTD | PMID:23146750 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:731062 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BHLHE41 mRNA | CTD | PMID:19191707 |
| 5-fluorouracil | affects response to substance | ISO | RGD:731061 | 6480464 | BHLHE41 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of BHLHE41 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731062 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of BHLHE41 mRNA | CTD | PMID:21715664 |
| cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of BHLHE41 mRNA | CTD | PMID:18500788 |
| chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of BHLHE41 mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:731062 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:731061 | 6480464 | [Cisplatin co-treated with LBH589] affects the expression of BHLHE41 mRNA; more ... | CTD | PMID:21791302 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of BHLHE41 mRNA | CTD | PMID:22023808 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of BHLHE41 mRNA | CTD | PMID:17602206 |
| dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BHLHE41 mRNA] | CTD | PMID:20032058 |
| dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of BHLHE41 mRNA | CTD | PMID:20032058 |
| diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of BHLHE41 mRNA | CTD | PMID:21161181 |
| diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of BHLHE41 mRNA | CTD | PMID:21551480 |
| folic acid | multiple interactions | ISO | RGD:731062 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene | CTD | PMID:20938992 |
| ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of BHLHE41 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | ISO | RGD:731062 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene | CTD | PMID:20938992 |
| N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of BHLHE41 mRNA | CTD | PMID:16026605 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BHLHE41 mRNA | CTD | PMID:18164116 |
| nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of BHLHE41 mRNA | CTD | PMID:22110744 |
| paracetamol | affects expression | ISO | RGD:731062 | 6480464 | Acetaminophen affects the expression of BHLHE41 mRNA | CTD | PMID:17562736 |
| phenobarbital | affects expression | ISO | RGD:731061 | 6480464 | Phenobarbital affects the expression of BHLHE41 mRNA | CTD | PMID:19159669 |
| progesterone | multiple interactions | ISO | RGD:731061 | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of BHLHE41 mRNA | CTD | PMID:17404688 |
| sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of BHLHE41 mRNA | CTD | PMID:15967596 |
| testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BHLHE41 mRNA] | CTD | PMID:20032058 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of BHLHE41 mRNA | CTD | PMID:21515302 |
| undecane | increases expression | EXP | | 6480464 | undecane results in increased expression of BHLHE41 protein | CTD | PMID:17337753 |